OBJECTIVES: To assess the incidence, risk factors, and outcomes of atrial fibrillation (AF) in the ICU and to describe current practice in the management of AF. DESIGN: Multicenter, prospective, inception cohort study. SETTING: Forty-four ICUs in 12 countries in four geographical regions. SUBJECTS: Adult, acutely admitted ICU patients without a history of persistent/permanent AF or recent cardiac surgery were enrolled; inception periods were from October 2020 to June 2021. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We included 1,423 ICU patients and analyzed 1,415 (99.4%), among whom 221 patients had 539 episodes of AF. Most (59%) episodes were diagnosed with continuous electrocardiogram monitoring. The incidence of AF was 15.6% (95% CI, 13.8–17.6), of which newly developed AF was 13.3% (11.5–15.1). A history of arterial hypertension, paroxysmal AF, sepsis, or high disease severity at ICU admission was associated with AF. Used interventions to manage AF were fluid bolus 19% (95% CI 16–23), magnesium 16% (13–20), potassium 15% (12–19), amiodarone 51% (47–55), beta-1 selective blockers 34% (30–38), calcium channel blockers 4% (2–6), digoxin 16% (12–19), and direct current cardioversion in 4% (2–6). Patients with AF had more ischemic, thromboembolic (13.6% vs 7.9%), and severe bleeding events (5.9% vs 2.1%), and higher mortality (41.2% vs 25.2%) than those without AF. The adjusted cause-specific hazard ratio for 90-day mortality by AF was 1.38 (95% CI, 0.95–1.99). CONCLUSIONS: In ICU patients, AF occurred in one of six and was associated with different conditions. AF was associated with worse outcomes while not statistically significantly associated with 90-day mortality in the adjusted analyses. We observed variations in the diagnostic and management strategies for AF.
Pleural fluid malondialdehyde (PMDA) and serum effusion albumin gradient(SEAG) were estimated in 60 patients of pleural effusion of diverse etiologies. The results were compared with Light's criteria to distinguish between transudates and exudates. The mean PMDA level was 0.68±0.24nmol/ml and 1.17±0.25nmol/ml in transudates and exudates respectively showing a statistically significant (p<0.05) rise in exudates in comparison to transudates. SEAG registered a significant fall in exudates (P<0.001) when compared with transudates. PMDA revealed a positive correlation with pleural protein(r=+0.30) and a significant negative association with SEAG (r= -0.33).Sensitivity and specificity of PMDA were better than the parameters of Light's criteria.Whereas SEAG documented approximately equal sensitivity, specificity, positive predictive value (PPV) and negative predictive value ( NPV) with Light's criteria. Therefore PMDA and SEAG can be taken together in addition to Light's criteria to strengthen the discrimination between transudates and exudates in borderline cases of pleural effusion.
BACKGROUND Tuberculosis, an important preventable and treatable cause of death is a major health problem worldwide. However, in patients with a compatible clinical picture, sputum smear don't reveal acid-fast bacilli in all patients. So, alternative methods of obtaining sputum specimen are frequently needed in these patients. Rapid diagnosis of tuberculosis and detection of rifampicin (RIF) resistance are essential for effective disease management. CBNAAT (cartridge based nucleic acid amplification test) (DS Sowjanya, et al) 1 is a novel integrated diagnostic device for diagnosis of tuberculosis and rapid detection of RIF resistance in clinical specimen. The aim of the study is to study different diagnostic modalities in sputum smear negative patients with special reference to CBNAAT. MATERIALS AND METHODS This was an observational study done in the Department of Pulmonary Medicine, SCBMCH, Cuttack. 100 patients were selected for the study. In all patients, induced sputum was sent for smear acid-fast bacilli. Those patients whose induced sputum was negative were undergone bronchoscopy for BAL (bronchoalveolar lavage). The specimen was sent for smear acid-fast bacilli, sputum CBNAAT and culture for Mycobacterium tuberculosis.
Background and objectivesTuberculosis (TB) is an airborne contagious illness caused by Mycobacterium tuberculosis. Ineffective anti-TB medication prolongs and exasperates illness, promotes disease spread, increases the probability of developing resistance to treatment, and increases death rate. Bedaquiline (BDQ) and Delamanid (DLM) were conditionally made available in the treatment of multidrug-resistant TB (MDR TB). In drug-resistant TB patients, adverse drug reactions (ADR) management is essential to improve medication compliance. In addition, we performed this study since there are very few studies published on the analysis of ADR monitoring of BDQ and DLM-based regimen. This study was performed to study the spectrum of ADR in drug-resistant TB patients receiving BDQ and DLM-based regimen. MethodologyThe study was conducted over a period of 26 months, in a hospital's departments of pharmacology and pulmonary medicine. Pre-extensively drug-resistant (Pre-XDR) and XDR TB were established on the basis of cartridge-based nucleic acid amplification (CB-NAAT), line probe assay (LPA), drug susceptibility testing (DST), and bacteriological culture. Patients were prescribed with appropriate medicines at the initial visit and any adverse reactions to medication were assessed in the subsequent visit. The statistical analysis was done using frequency distribution procedure, chi-square test of independence. The significance level was set at p<0.05. ResultsIt was revealed that there were as many as 24 types of ADRs manifested in different patients. The most frequent ADR was QTcF (corrected heart rate) prolongation. ConclusionThe maximum number of patients had some form of ADR and the percentage was slightly higher in the BDQ group than in the DLM group.
Background: According to Revised National Tuberculosis Control Program (RNTCP), diagnosis of pulmonary tuberculosis (TB) in India requires examination of two sputum samples collected over 2 days, that is, “spot” and next day “morning” samples. Objective: To assess the feasibility of diagnosing pulmonary TB by examining two spot sputum samples in 1 day and to compare this approach with the current RNTCP protocol. Materials and Method: A total of 375 subjects having cough >2 weeks were enrolled into the study. Three sputum samples were collected from each of the study participant; first spot (S1), second extra-spot (S2) sample 1 h after collection of the first sample, and third morning (M) sample collected next day morning. These specimens were subjected to standard sputum smear microscopy for acid-fast bacilli as per RNTCP guidelines. For 1-day protocol, results of “S1 and S2” samples and for 2-day protocol results of “S1 and M” samples were considered. Results: The number of sputum-positive pulmonary TB cases diagnosed with standard 2-day protocol was 119, whereas the experimental 1-day protocol diagnosed 120 cases ( P = 0.7). Comparing with standard 2-day protocol, this new 1-day protocol had sensitivity 98.32%, specificity 100%, positive predictive value 100%, and negative predictive value 99.17%. Conclusion: Single-day method can be adopted as the standard diagnostic approach for pulmonary TB after large-scale multicenter randomized controlled trials.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.